PFIZER INC Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- PFIZER INC stock issued during period, value, stock options exercised for fiscal 2013 was $2.30B, a 117.42% increase from fiscal 2012.
- PFIZER INC stock issued during period, value, stock options exercised for fiscal 2012 was $1.06B, a 109.11% increase from fiscal 2011.
- PFIZER INC stock issued during period, value, stock options exercised for fiscal 2011 was $505.00M, a 258.16% increase from fiscal 2010.
- PFIZER INC stock issued during period, value, stock options exercised for fiscal 2010 was $141.00M, a 1.44% increase from fiscal 2009.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2013-12-31 | $2.30B 10-K · filed 2014-02-28 | |
| 2012-12-31 | $1.06B 10-K · filed 2014-02-28 | |
| 2011-12-31 | $505.00M 10-K · filed 2014-02-28 | |
| 2010-12-31 | $141.00M 10-K · filed 2013-02-28 | |
| 2009-12-31 | $139.00M 10-K · filed 2012-02-28 | |
| 2008-12-31 | $239.00M 10-K · filed 2011-02-28 | |
| 2007-12-31 | $853.00M 10-K · filed 2010-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |